Skip to main content

Advertisement

SpringerLink
Log in

Stimulation of natural killer cytotoxicity by long-term treatment with double-stranded polynucleotides without induction of hyporesponsiveness

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Treatment of Wistar/AG rats with a single i.p. injection of 1 mg/kg of synthetic double-stranded polynucleotides, either polyadenylic-polyuridylic acid (rAn.rUn), or a mismatched analogue of polyinosinic-polycytidylic acid (rIn.r(C12U)n), enhanced the cytotoxicity of natural killer (NK) cells among peripheral blood leukocytes and lung intracapillary leukocytes (LICL). The enhancement reached a peak 24 h after treatment and returned to control values after 4 days. In rats given repeated injections of double-stranded polynucleotides (2 per week), the NK cytotoxicity expressed by LICL reached more than ten times (in lytic units) the control levels between day 8, after 3 injections, and day 360, after 100 injections. No hypore-sponsiveness was observed. Moreover, NK activity was frequently and significantly higher in rats given multiple injections than in those given a single injection. In rats with experimentally induced P77 lung fibrohistiocytoma colonies, repeated injections of rIn.r(C12U)n stimulated NK activity and reduced the number of metastatic nodules from 172 to 19. The same significant reduction (from 172 to 27) was also observed in animals given repeated injections of rAn.rUn. However, with two models of spontaneous metastases, significant reduction in lung metastases (M37 bronchioloalveolar carcinoma) or lack of effect (S4T19 rhabdomyosarcoma) were observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aurelian L, Rinehart CL, Wachsman M, Kulka M, Ts'o POP (1987) Augmentation of natural immune defence mechanisms and therapeutic potential of a mismatched double-stranded polynucleotide in cutaneous Herpes simplex virus type 2 infection. J Gen Virol 68:2831–2838

    Google Scholar 

  2. Barlozzari T, Leonhardt J, Wiltrout RH, Herberman RB, Reynolds CW (1985) Direct evidence for the role of LGL in the inhibition of experimental tumor metastasis. J Immunol 134:2783–2789

    Google Scholar 

  3. Besançon F, Silbermann F, Dron M, Tovey MG, Thang MN, Bourgeade MF (1987) Relationship between inhibition of cell growth and of transferrin receptor expression by interferon (IFN) α: studies in IFN-sensitive and IFN-resistant Daudi cells. J Gen Virol 68:2647–2654

    Google Scholar 

  4. Brodsky I, Strayer DR, Krueger LJ, Carter WA (1985) Clinical studies with Ampligen (mismatched double-stranded RNA). J Biol Response Mod 4:669–675

    Google Scholar 

  5. Carter WA, O'Malley J, Beeson M, Cunnington P, Kelvin A, Vere-Hodge A (1976) An integrated and comparative study of the antiviral effect and biological properties of the polyinosinic-polycytidylic acid duplex and its mismatched analogues. III. Chronic effects and immunological features. Mol Pharmacol 12:440–453

    Google Scholar 

  6. Carter WA, Hubbell HR, Krueger LJ, Strayer DR (1985) Comparative studies of ampligen (mismatched double-stranded RNA) and interferons. J Biol Response Mod 4:613–620

    Google Scholar 

  7. Carter WA, Strayer DR, Brodsky I, Lewin M, Pellegrino MG, Einck L, Henriques HF, Simon GL, Parenti DM, Scheib RG, Schulof RS, Montefiori DC, Robinson WE, Mitchell WM, Volsky DJ, Paul D, Paxton H, Meyer WA, Kariko K, Reichenbach N, Suhadolnik RJ, Gillespie DH (1987) Clinical, immunological and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS-related complex. Lancet I:1286–1292

    Google Scholar 

  8. Djeu JY, Heinbaugh JA, Holden HT, Herberman RB (1979) Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 122:175–180

    Google Scholar 

  9. Field AK, Tytell AA, Lampson GP, Hilleman MR (1967) Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci USA 58:1004–1009

    Google Scholar 

  10. Golub SH (1982) NK cytotoxicity in interferon treated melanoma patients. In: Herberman RB (ed) NK cells and other natural effector cells. Academic Press, New York, pp 1265–1271

    Google Scholar 

  11. Habu S, Sukui H, Shimamura K, Kasai M, Nagai Y, Okumura K, Tamaoki N (1981) In vivo effect of anti-asialo GM1. 1) Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol 127:34–38

    Google Scholar 

  12. Hanna N, Burton RC (1981) Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo. J Immunol 127:1754–1758

    Google Scholar 

  13. Hanna N, Fidler IJ (1980) Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst 65:801–809

    Google Scholar 

  14. Herberman RB, Pinsky C (1985) Polyribonucleotides for cancer therapy: summary and recommendations for further research. J Biol Response Mod 4:680–684

    Google Scholar 

  15. Herberman RB, Nunn ME, Lavrin DH (1975) Natural cytotoxicity reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. Distribution of reactivity and specificity. Int J Cancer 16:216–239

    Google Scholar 

  16. Krown SE, Kerr D, Stewart WE, Field AK, Oettgen HF (1985) Phase I trials of poly (L, C) complexes in advanced cancer. J Biol Response Mod 4:640–649

    Google Scholar 

  17. Lacour J, Lacour F, Spira A, Michelson M, Petit JY, Delage G, Sarrazin D, Contesso G, Viguier J (1980) Adjuvant treatment with polyadenylic-polyuridylic acid (Poly A. Poly U) in operable breast cancer. Lancet II:161–164

    Google Scholar 

  18. Lacour J, Lacour F, Spira A, Michelson M, Petit JY, Delage G, Sarrazin D, Contesso G, Viguier J (1984) Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer; updated results of a randomised trial. Br Med J 288:589–592

    Google Scholar 

  19. Laurence J, Kulkosky J, Friedman SM, Posnett DN, Ts'o POP (1987) Poly I.poly C12U-mediated inhibition of loss of alloantigen responseness and viral replication in human CD4+ T cell clones exposed to human immunodeficiency virus in vitro. J Clin Invest 80:1631–1639

    Google Scholar 

  20. Lotzova E, Savary CA, Quesada JR, Gutterman JU, Hersh E (1983) Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon. J Natl Cancer Inst 71:903–910

    Google Scholar 

  21. Maluish AE, Ortaldo JR, Cowlon JC, Sherwin SA, Leavitt DM, Strong P, Weirnik R, Oldham RK, Herberman RB (1983) Depression of natural killer cytotoxicity, following in vivo administration of recombinant leukocyte interferon. J Immunol 131:503–507

    Google Scholar 

  22. Michelson AM, Lacour F, Lacour J (1985) Polyadenylic-polyuridylic acid in the cotreatment of cancer. Proc Soc Exp Biol Med 179:1–8

    Google Scholar 

  23. Montefiori DC, Mitchell WM (1987) Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro. Proc Natl Acad Sci USA 84:2985–2989

    Google Scholar 

  24. Montefiori WM, Montefiori DC, Robinson WE, Strayer DR, Carter WA (1987) Mismatched double-stranded RNA (ampligen) reduces the concentration of zidovudine (azidothymidine) required for in vivo inhibition of human immunodeficiency virus. Lancet I:890–892

    Google Scholar 

  25. Nolibe D, Poupon MF (1986) Enhancement of pulmonary metastases by decreased lung natural killer cell activity. J Natl Cancer Inst 77:99–103

    Google Scholar 

  26. Nolibe D, Thang MN (1985) Inhibition of experimental metastases by ds polynucleotides. In: Hellmann K, Eccles SA (eds) Treatment of metastasis, problems and prospects. Taylor and Francis, London, pp 145–148

    Google Scholar 

  27. Nolibe D, Berel E, Masse R, Lafuma J (1981) Characterization of a major natural killer activity in rat lungs. Biomedicine 35:230–234

    Google Scholar 

  28. Nolibe D, Aumaitre E, Thang MN (1985) In vivo augmentation of rat lung natural killer cell activity and inhibition of experimental metastases by double-stranded polynucleotides. Cancer Res 45:4774–4778

    Google Scholar 

  29. Riccardi C, Puccetti P, Santoni A, Herberman RB (1979) Rapid in vivo assay of mouse natural killer cell activity. J Natl Cancer Inst 63:1041–1045

    Google Scholar 

  30. Stevenson HC, Abrams PG, Schoenberger CS, Smalley RB, Herberman RB, Foon KA (1985) A phase I evaluation of Poly (I, C) LC in cancer patients. J Biol Response Mod 4:650–655

    Google Scholar 

  31. Strayer DR, Watson P, Carter WA, Brodsky I (1986) Antiproliferative effect of mismatched double-stranded RNA on fresh human tumor cells analysed in a clonogenic assay. J Int Res 6:373–379

    Google Scholar 

  32. Sweeney FL, Pot-Deprun J, Poupon MF (1982) Heterogeneity of the growth and metastatic behavior of cloned cell lines derived from a primary rhabdomyosarcoma. Cancer Res 42:3776–3782

    Google Scholar 

  33. Talmadge JE, Meyers KM, Prieur DJ, Starkey JR (1980) Role of natural killer cells in tumor growth and metastasis: C57 BL/6 normal and beige mice. J Natl Cancer Inst 65:929–935

    Google Scholar 

  34. Talmadge JE, Herberman RB, Chirigos MA, Maluish AE, Schneider MA, Adams JS, Philips H, Thurman GB, Varesio L, Long C, Oldham RK, Wiltrout RH (1985) Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2. J Immunol 135:2485–2491

    Google Scholar 

  35. Ts'o POP, Alderfer J, Levy J (1976) An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic acid — polycytidylic acid and its mismatched analogues. Mol Pharmacol 12:299–312

    Google Scholar 

  36. Wathelet MG, Clauss IM, Nols CB, Content J, Huez GA (1987) New inducers revealed by the promoter sequence analysis of two interferon-activated human genes. Eur J Biochem 169:313–321

    Google Scholar 

  37. Wiltrout RH, Herberman RB, Zhang SR, Chirigos MA, Ortaldo JR, Green KM, Talmadge JE (1985) Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 134:4267–4275

    Google Scholar 

  38. Wong GHW, Goeddel DV (1986) Tumor necrosis factor α and β inhibit virus replication and synergize with interferons. Nature 323:819–822

    Google Scholar 

  39. Zullo JN, Cochran BH, Huang AS, Stiles CD (1985) Plateletderived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell 43:793–800

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. C. E. A./IPSN/DPS/SPE/STCE/Laboratoire de Toxicologie des Transuraniens, BP No 12, F-91680, Bruyères le Châtel, France

    D. Nolibe

  2. INSERM U 245, Centre INSERM Saint-Antoine, 184, rue du Fg Saint-Antoine, F-75571, Paris Cédex 12, France

    M. N. Thang

Authors
  1. D. Nolibe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. N. Thang
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nolibe, D., Thang, M.N. Stimulation of natural killer cytotoxicity by long-term treatment with double-stranded polynucleotides without induction of hyporesponsiveness. Cancer Immunol Immunother 27, 114–120 (1988). https://doi.org/10.1007/BF00200014

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00200014

Keywords

Search

Navigation